Drug Trial News

RSS
ImmunoCellular reports updated ICT-107 Phase I trial data in glioblastoma multiforme

ImmunoCellular reports updated ICT-107 Phase I trial data in glioblastoma multiforme

6 May 2011
Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

6 May 2011
Pacira to present EXPAREL data in postsurgical pain at two medical meetings

Pacira to present EXPAREL data in postsurgical pain at two medical meetings

6 May 2011
Omeros' PDE7 program expands addiction franchise

Omeros' PDE7 program expands addiction franchise

6 May 2011
MMRF, APGD collaborate to develop OSI-906 for relapsed multiple myeloma treatment

MMRF, APGD collaborate to develop OSI-906 for relapsed multiple myeloma treatment

6 May 2011
Furiex Pharmaceuticals to present two JNJ-Q2 antibiotic abstracts at ECCMID/ ICC congress

Furiex Pharmaceuticals to present two JNJ-Q2 antibiotic abstracts at ECCMID/ ICC congress

6 May 2011
Promedior's PRM-151 clinical data in idiopathic pulmonary fibrosis to be presented at ATS 2011

Promedior's PRM-151 clinical data in idiopathic pulmonary fibrosis to be presented at ATS 2011

5 May 2011
Over 1000 patients enrolled in world's largest ever pancreatic cancer vaccine trial

Over 1000 patients enrolled in world's largest ever pancreatic cancer vaccine trial

5 May 2011
Clinical study: Celecoxib drug may treat breast cancer

Clinical study: Celecoxib drug may treat breast cancer

5 May 2011
CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

5 May 2011
Selexys begins patient enrollment in SelG1 Phase I study for sickle cell disease

Selexys begins patient enrollment in SelG1 Phase I study for sickle cell disease

5 May 2011
FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

4 May 2011
PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

4 May 2011
SARcode reports encouraging data from SAR 1118 Phase 2 dry eye trial

SARcode reports encouraging data from SAR 1118 Phase 2 dry eye trial

4 May 2011
pSivida presents data of ILUVIEN Phase 3 trial in Diabetic Macular Edema at ARVO 2011

pSivida presents data of ILUVIEN Phase 3 trial in Diabetic Macular Edema at ARVO 2011

4 May 2011
Top-line results from Lymphoseek NEO3-09 Phase 3 study in breast cancer, melanoma

Top-line results from Lymphoseek NEO3-09 Phase 3 study in breast cancer, melanoma

4 May 2011
Nile Therapeutics initiates cenderitide Phase I trial in heart failure

Nile Therapeutics initiates cenderitide Phase I trial in heart failure

3 May 2011
Santarus' budesonide MMX Phase III data in ulcerative colitis to be presented at DDW 2011

Santarus' budesonide MMX Phase III data in ulcerative colitis to be presented at DDW 2011

3 May 2011
Affinium announces AFN-1252 Phase I study results in staphylococcal infections

Affinium announces AFN-1252 Phase I study results in staphylococcal infections

3 May 2011
Esperion reports positive results from ETC-1002 Phase 1 study in dyslipidemia

Esperion reports positive results from ETC-1002 Phase 1 study in dyslipidemia

3 May 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback